URAC Infusion Pharmacy Accreditation Consulting

Preparing infusion pharmacies and home infusion therapy suppliers for URAC accreditation — from initial gap analysis through final decision.

Schedule a Free Discovery Session

Last updated: April 2026

What Is URAC Infusion Pharmacy Accreditation?

URAC Infusion Pharmacy Accreditation is a voluntary quality credential awarded to pharmacies and infusion therapy organizations that meet URAC's rigorous standards for patient management, pharmacy operations, safety, and coordinated multidisciplinary care. The program covers infusion therapy services provided to patients in the home and other ambulatory care settings — excluding Medicare patients, who are covered under a separate URAC Medicare Home Infusion Therapy Supplier Accreditation program.

IHS brings an unmatched perspective to infusion pharmacy accreditation consulting. Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC, built and oversaw many of the standards your organization will be evaluated against. That insider knowledge translates directly into preparation that is precise, efficient, and grounded in how URAC reviewers actually read submissions.

Two Distinct URAC Infusion Programs

URAC offers two separate accreditation programs for infusion services. Understanding which applies to your organization — or whether you need both — is the first strategic decision in your accreditation journey.

Infusion Pharmacy Accreditation

For pharmacies dispensing infusion medications and providing infusion services to non-Medicare patients in home or ambulatory care settings. Standards address infusion management and pharmacy operations across all patient populations except Medicare.

  • Home infusion pharmacies serving commercial, Medicaid, and self-pay patients
  • Hospital outpatient infusion programs
  • Ambulatory infusion centers operating pharmacy services
  • Specialty pharmacies expanding into infusion therapy

Medicare Home Infusion Therapy Supplier Accreditation

Mandated by the 21st Century Cures Act for organizations seeking reimbursement as Medicare Home Infusion Therapy Suppliers. CMS requires accreditation by a CMS-approved organization — URAC is one of those organizations. Standards address infusion management for Medicare beneficiaries receiving therapy at home.

  • Pharmacies billing Medicare for home infusion therapy services
  • Organizations seeking Medicare HIT supplier status
  • Home infusion providers expanding to Medicare patient populations

Many organizations pursue both accreditations simultaneously. IHS can design a coordinated preparation strategy that satisfies requirements for both programs without duplicating effort.

What URAC Evaluates

URAC's Infusion Pharmacy standards are organized across operational domains that span the full patient care and pharmacy operations continuum. While the complete standards are available through URAC directly, the core evaluation areas include:

Patient Management

Patient assessment, care planning, clinical monitoring, outcomes tracking, patient education and engagement, and coordination with the prescribing and clinical team across the infusion therapy episode.

Pharmacy Operations

Dispensing accuracy, sterile compounding compliance (including USP <797> and USP <800> alignment), labeling, storage and handling, and pharmacy staffing and oversight structures.

Infusion Management

Coordination of the full infusion therapy episode — from initial referral and benefits investigation through therapy initiation, ongoing monitoring, and episode closure. Includes home nursing coordination and clinical escalation pathways.

Quality Management

Performance measurement, quality improvement program structure, adverse event tracking and reporting, and continuous improvement cycles tied to clinical and operational metrics.

Risk Management and Safety

Risk identification, mitigation, and response protocols specific to infusion therapy. Includes medication error reporting, adverse drug event monitoring, and patient safety program design.

Consumer Protections

Patient rights and responsibilities, complaint and grievance processes, informed consent, and transparency requirements that URAC embeds across its accreditation programs as foundational consumer protection standards.

Staff Qualifications and Training

Credentialing and competency verification for pharmacists, pharmacy technicians, and clinical staff involved in infusion therapy delivery. Ongoing training requirements and documentation standards.

Operations and Infrastructure

Organizational governance, compliance program structure, delegation oversight if services are subcontracted, and information management systems supporting infusion therapy delivery.

Who Pursues URAC Infusion Pharmacy Accreditation

Home Infusion Pharmacies

Organizations primarily structured around home infusion therapy — including antibiotics, TPN, pain management, immunoglobulin, and other complex infusion therapies — seeking a quality credential that validates their clinical and operational model to payers and referral sources.

Medicare Billing Organizations

Any pharmacy or supplier seeking reimbursement under the Medicare Home Infusion Therapy benefit is required by law to hold accreditation from a CMS-approved organization. URAC's MHITS program is one of the recognized pathways.

Specialty Pharmacies Expanding Into Infusion

Specialty pharmacies adding infusion therapy to their service lines often pursue URAC Infusion Pharmacy Accreditation alongside or following their Specialty Pharmacy Accreditation. URAC's coordinated standards framework reduces redundant documentation.

Health Systems and Hospital Outpatient Programs

Hospital outpatient pharmacies and infusion centers expanding ambulatory infusion services increasingly seek URAC accreditation to satisfy payer contracting requirements and differentiate their programs from lower-acuity alternatives.

Payer-Required Accreditation

Many commercial payers and PBMs now require URAC or equivalent accreditation as a condition of preferred or exclusive network status for infusion therapy providers. Organizations contracting with these payers must achieve and maintain accreditation to remain in network.

The Accreditation Process

URAC states that organizations can achieve full accreditation in six months or less once the process begins. In practice, the actual preparation timeline — before the formal URAC process starts — is where most organizations either gain or lose ground. IHS structures preparation to be thorough without generating unnecessary documentation volume.

  1. Gap Analysis

    IHS conducts a structured assessment of your current policies, procedures, and operational practices against URAC's Infusion Pharmacy standards. The gap analysis produces a prioritized remediation plan with clear assignments and timelines.

  2. Standards Education

    Your team needs to understand not just what the standards say, but how URAC reviewers interpret them. IHS translates URAC's standards language into operational requirements your clinical, pharmacy, and administrative staff can implement accurately.

  3. Policy and Procedure Development

    Policy and procedure development is consistently the most time-intensive phase of URAC preparation. URAC requires evidence of effective dates, review dates, revision history, and approval authority for every policy. IHS provides templates and builds your policy library to URAC's documentation requirements.

  4. Evidence File Organization

    URAC's desktop review process requires organized, labeled evidence mapped to specific standards. IHS structures your evidence file so reviewers can find what they need without ambiguity — reducing back-and-forth and RFI risk.

  5. Mock Desktop Review

    Before submitting to URAC, IHS conducts a mock desktop review that mirrors URAC's actual review process. Gaps identified at this stage are addressed before submission, not after a deficiency finding.

  6. Submission and RFI Support

    IHS supports the submission process and remains available through URAC's review cycle. If URAC issues a Request for Information (RFI) or deficiency finding, IHS prepares the response.

Common Challenges in Infusion Pharmacy Accreditation

Policy and Procedure Volume

URAC requires comprehensive policies covering both clinical and operational domains. First-time applicants routinely underestimate the breadth of documentation required — and the specificity URAC expects in policy content, approval chains, and review cycles.

USP Compliance Integration

Infusion pharmacies engaged in sterile compounding must align their practices with USP <797> (sterile compounding) and USP <800> (hazardous drugs). URAC's standards reference these requirements, and gaps in USP compliance surface as accreditation deficiencies.

Quality Management Program Structure

URAC's quality management standards require an active, documented program — not a binder of policies that are reviewed annually. Organizations that have not built a functioning QI program before applying often find this the most difficult domain to satisfy on the URAC timeline.

Delegation Oversight

Infusion pharmacies that subcontract clinical services — nursing, home health coordination — must demonstrate active oversight of those delegated functions. URAC's delegation standards require documented agreements, performance monitoring, and corrective action capability.

Staff Competency Documentation

URAC requires evidence that staff involved in infusion therapy are qualified for their roles and that competency is assessed and documented on an ongoing basis. Many organizations have the competency programs but lack the documentation structure URAC requires.

Medicare-Specific Requirements for MHITS

Organizations pursuing the Medicare Home Infusion Therapy Supplier Accreditation face an additional layer of CMS-aligned requirements on top of URAC's standards. Navigating the intersection of URAC standards and Medicare conditions of participation requires experience with both frameworks.

Why Organizations Choose IHS

IHS is led by Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC. That credential is not marketing language — it reflects direct operational responsibility for the standards your organization is being evaluated against. When IHS interprets a URAC standard, that interpretation is grounded in the intent behind the standard, not speculation about what reviewers are looking for.

  • Insider standards knowledge. IHS understands URAC's standards at the policy architecture level — how they were designed, what gaps they were intended to close, and how reviewers are trained to read them.
  • No unnecessary documentation volume. URAC preparation does not require building an entire administrative apparatus from scratch. IHS targets preparation to the actual requirements, not a maximalist interpretation of them.
  • Policy development that passes review. IHS policy templates are built to URAC's documentation standards — not generic pharmacy policy templates that require extensive rework before they satisfy a URAC reviewer.
  • Dual-program coordination. For organizations pursuing both Infusion Pharmacy Accreditation and Medicare Home Infusion Therapy Supplier Accreditation, IHS designs a coordinated preparation strategy that avoids duplicating documentation effort.
  • Post-accreditation maintenance support. Achieving accreditation is not the end of the compliance obligation. IHS offers ongoing support for policy maintenance, quality program monitoring, and re-accreditation preparation.

Ready to Begin?

A discovery session with IHS starts with your specific situation — where you are in the accreditation process, what URAC has already indicated, and what the realistic path to accreditation looks like for your organization. Engagement fees are scoped per engagement — contact for a proposal.

Schedule a Free Discovery Session